Standard BioTools
People in the News at Oxford Nanopore Technologies, Standard BioTools, Myriad Genetics
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Standard BioTools Lowers Full-Year Revenue Guidance as Q2 Revenues Fall 23 Percent
SomaScanassay services experienced service contract delays in Q2, impacting instrument sales, CEO Michael Egholm said.
Reversing Previous Findings, Corrected Decode Paper Shows SomaScan More Precise Than Olink Explore
Premium
Olink's platform appears to have better specificity, but many researchers suggest such comparisons are less useful than better understanding both tools' capabilities.
Standard BioTools Q1 Revenues Grow 81 Percent After SomaLogic Merger
Revenues grew 2 percent year over year on a pro forma basis following the completion of the merger with SomaLogic in early January.
Standard BioTools Lays off 10 Percent of Staff in Operational Restructuring
The company expects to reduce annual operating expenses by $45 million to $50 million in fiscal year 2025, with most of the cuts happening in the second half of 2024.
Feb 28, 2024
Standard BioTools Q4 Revenues Grow 4 Percent
Oct 11, 2023
Oct 4, 2023